Effects of 17β-estradiol and progesterone on the production of adipokines in differentiating 3T3-L1 adipocytes: Role of Rho-kinase

Cytokine

Volumn 72, Issue 2, 2015, Pages 130-134

  Pektaş, Mehtap ^a   Kurt, Akif Hakan ^b   Ün, Ismail ^a   Tiftik, Rukiye Nalan ^a   Büyükafşar, Kansu ^a  

^a Mersin University Campus Ciftlikkoy ^*  (Turkey)

^b KAHRAMANMARAS SUTCU IMAM UNIVERSITY   (Turkey)

Author keywords

17 estradiol; Adipocyte; Adipokines; Progesterone; Rho kinase

Indexed keywords

4 (1 AMINOETHYL) N (4 PYRIDYL)CYCLOHEXANECARBOXAMIDE; ADIPOCYTOKINE; ADIPONECTIN; DEXAMETHASONE; ESTRADIOL; INSULIN; INTERLEUKIN 6; ISOBUTYLMETHYLXANTHINE; LEPTIN; MONOCLONAL ANTIBODY; PROGESTERONE; RESISTIN; RHO KINASE; RHO KINASE INHIBITOR; TUMOR NECROSIS FACTOR ALPHA; AMIDE; CYTOKINE; PYRIDINE DERIVATIVE;

3T3 CELL LINE; ADIPOCYTE; ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; CULTURE MEDIUM; CYTOKINE PRODUCTION; ELISA KIT; HORMONE ACTION; NONHUMAN; PROADIPOCYTE; ADIPOGENESIS; ANIMAL; BIOSYNTHESIS; BOVINE; CYTOLOGY; DRUG EFFECTS; ENZYME LINKED IMMUNOSORBENT ASSAY; METABOLISM; MOUSE; PHYSIOLOGY; SIGNAL TRANSDUCTION;

BOVINAE;

3T3-L1 CELLS; ADIPOCYTES; ADIPOGENESIS; ADIPOKINES; ADIPONECTIN; AMIDES; ANIMALS; CATTLE; CYTOKINES; ENZYME-LINKED IMMUNOSORBENT ASSAY; ESTRADIOL; INTERLEUKIN-6; LEPTIN; MICE; PROGESTERONE; PYRIDINES; RESISTIN; RHO-ASSOCIATED KINASES; SIGNAL TRANSDUCTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84922019061     PISSN: 10434666     EISSN: 10960023     Source Type: Journal    
DOI: 10.1016/j.cyto.2014.12.020     Document Type: Article

References (45)

1. Ambati S., Kim H.K., Yang J.Y., Lin J., Della-Fera M.A., Baile C.A. Effects of leptin on apoptosis and adipogenesis in 3T3-L1 adipocytes. Biochem Pharmacol 2007, 73:378-384.
2. Barandier C., Ming X.F., Rusconi S., Yang Z. PKC is required for activation of ROCK by RhoA in human endothelial cells. Biochem Biophys Res Commun 2003, 304:714-719.
3. Chen Y.H., Lee M.J., Chang H.H., Hung P.F., Kao Y.H. 17 beta-estradiol stimulates resistin gene expression in 3T3-L1 adipocytes via the estrogen receptor, extracellularly regulated kinase, and CCAAT/enhancer binding protein-alpha pathways. Endocrinology 2006, 147:4496-4504.
4. Collins T. Acute and chronic inflammation: Robbins Pathologic Basis of Disease. In: Cotran RS, Kumar V, Collins T, Bobbins SL, editors, WB Saunders, 6th ed. Philadelphia: 1999. p. 56-88.
5. Collison M., Campbell I.W., Salt I.P., Dominiczak A.F., Connell J.M., Lyall H., et al. Sex hormones induce insulin resistance in 3T3-L1 adipocytes by reducing cellular content of IRS proteins. Diabetologia 2000, 43:1374-1380.
6. Casabiell X., Piñeiro V., Peino R., Lage M., Camiña J., Gallego R., et al. Gender differences in both spontaneous and stimulated leptin secretion by human omental adipose tissue in vitro: dexamethasone and estradiol stimulate leptin release in women, but not in men. J Clin Endocrinol Metab 1998, 83:2149-2155.
7. Monjo M., Pujol E., Roca P. Alpha2- to beta3-Adrenoceptor switch in 3T3-L1 preadipocytes and adipocytes: modulation by testosterone, 17beta-estradiol, and progesterone. Am J Physiol Endocrinol Metab 2005, 289:E145-50.
8. Shimizu H., Shimomura Y., Nakanishi Y., Futawatari T., Ohtani K., Sato N., et al. Estrogen increases in vivo leptin production in rats and human subjects. J Endocrinol 1997, 154:285-292.
9. Hardie L., Trayhurn P., Abramovich D., Fowler P. Circulating leptin in women: a longitudinal study in the menstrual cycle and during pregnancy. Clin Endocrinol (Oxf) 1997, 47:101-106.
10. Fasshauer M., Klein J., Neumann S., Eszlinger M., Paschke R. Hormonal regulation of adiponectin gene expression in 3T3-L1 adipocytes. Biochem Biophys Res Commun 2002, 290:1084-1089.
11. Gong H., Ni Y., Guo X., Fei L., Pan X., Guo M., et al. Resistin promotes 3T3 L1 preadipocytedifferentiation. Eur J Endocrinol 2004, 150:885-892.
12. Gregoire M. Adipocyte differentiation: from fibroblast to endocrine cell. Exp Biol Med 2001, 226:997-1002.
13. Fukata Y., Amano M., Kaubuchi K. Rho-Rho-kinase pathway in smooth muscle contraction and cytoskeletal reorganization of non-muscle cells. Trends Pharmacol Sci 2001, 22:32-39.
14. Wettschureck N., Offermanns S. Rho/Rho-kinase mediated signaling in physiology and pathophysiology. J Mol Med (Berl) 2002, 80(10):629-638.
15. Ishizaki T., Maekawa M., Fujisawa K., Okawa K., Iwamatsu A., Fujita A., et al. The small GTP-binding protein Rho binds to and activates a 160kDa Ser/Thr protein kinase homologous to myotonic dystrophy kinase. EMBO J 1996, 15:1885-1893.
16. Sordella R., Jiang W., Chen G.C., Curto M., Settleman J. Modulation of Rho GTPase signaling regulates a switch between adipogenesis and myogenesis. Cell 2003, 113:147-158.
17. Noguchi M., Hosoda K., Fujikura J., Fujimoto M., Iwakura H., Tomita T., et al. Genetic and pharmacological inhibition of Rho-associated kinase II enhances adipogenesis. J Biol Chem 2007, 282:29574-29583.
18. Hosoyama T., Ishiguro N., Yamanouchi K., Nishihara M. Degenerative muscle fiber accelerates adipogenesis of intramuscular cells via RhoA signaling pathway. Differentiation 2009, 77:350-359.
19. Nakayama Y., Komuro R., Yamamoto A., Miyata Y., Tanaka M., Matsuda M., et al. RhoA induces expression of inflammatory cytokine in adipocytes. Biochem Biophys Res Commun 2009, 379:288-292.
20. Kratchmarova I., Kalume D.E., Blagoev B., Scherer P.E., Podtelejnikov A.V., Molina H., et al. A proteomic approach for identification of secreted proteins during the differentiation of 3T3-L1 preadipocytes to adipocytes. Mol Cell Proteomics 2002, 1:213-222.
21. Kanda T., Wakino S., Homma K., Yoshioka K., Tatematsu S., Hasegawa K., et al. Rho-kinase as a molecular target for insulin resistance and hypertension. FASEB J 2006, 20:169-171.
22. Karbowska J., Kochan Z. Role of Adiponectin in the regulation of carbonhydrate and lipid metabolism. J Physiol Pharmacol 2006, 57:103-113.
23. Mantzoros C.S. The role of leptin in human obesity and disease: a review of current evidence. Ann Intern Med 1999, 130:671-680.
24. Lappas M., Yee K., Permezel M., Rice G.E. Release and regulation of leptin, resistin and adiponectin from human placenta, fetal membranes, and maternal adipose tissue and skeletal muscle from normal and gestational diabetes mellitus-complicated pregnancies. J Endocrinol 2005, 186:457-465.
25. Lee M.J., Lin H., Liu C.W., Wu M.H., Liao W.J., Chang H.H., et al. Octylphenol stimulates resistin gene expression in 3T3-L1 adipocytes via the estrogen receptor and extracellular signal-regulated kinase pathways. Am J Physiol Cell Physiol 2008, 294:C1542-51.
26. Guzik T.J., Mangalat D., Korbut R. Adipocytokines - novel link between inflammation and vascular function?. J Physiol Pharmacol 2006, 57:505-528.
27. Kidani T., Kamei S., Miyawaki J., Aizawa J., Sakayama K., Bisphenol Masuno H., et al. Downregulates Akt signaling and inhibits adiponectin production and secretion in 3T3-L1 adipocytes. J Atheroscler Thromb 2010, 17:834-843.
28. Muraki K., Okuya S., Tanizawa Y. Estrogen receptor alpha regulates insulin sensitivity through IRS-1 tyrosine phosphorylation in mature 3T3-L1 adipocytes. Endocr J 2006, 53:841-851.
29. Murase Y., Kobayashi J., Nohara A., Asano A., Yamaaki N., Suzuki K., et al. Raloxifene promotes adipocyte differentiation of 3T3-L1 cells. Eur J Pharmacol 2006, 538:1-4.
30. Bastard J.P., Maachi M., Lagathu C., Kim M.J., Caron M., Vidal H., et al. Recent advances in the relationship between obesity, inflammation, and insulin resistance. Eur Cytokine Netw 2006, 17:4-12.
31. Yamauchi T., Kamon J., Waki H., Terauchi Y., Kubota N., Hara K., et al. The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med 2001, 7:941-946.
32. Kowalska I., Straczkowski M., Nikolajuk A., Adamska A., Karczewska-Kupczewska M., Otziomek E., et al. Insulin resistance, serum adiponectin, and proinflammatory markers in young subjects with the metabolic syndrome. Metabolism 2008, 57:1539-1544.
33. Yi K.W., Shin J.H., Seo H.S., Lee J.K., Oh M.J., Kim T., et al. Role of estrogen receptor-alpha and -beta in regulating leptin expression in 3T3-L1 adipocytes. Obesity (Silver Spring) 2008, 16:2393-2399.
34. Prossnitz E.R., Barton M. Signaling, physiological functions and clinical relevance of the G protein-coupled estrogen receptor GPER. Prostaglandins Other Lipid Mediat 2009, 89:89-97.
35. Bologa C.G., Revankar C.M., Young S.M., Edwards B.S., Arterburn J.B., Kiselyov A.S., et al. Virtual and biomolecular screening converge on a selective agonist for GPR30. Nat Chem Biol 2006, 2:207-212.
36. Kurt A.H., Buyukafsar K. Vasoconstriction induced by G1, a G-protein-coupled oestrogen receptor1 (GPER-1) agonist, in the isolated perfused rat kidney. Eur J Pharmacol 2013, 702:71-78.
37. Thirumala S., Gimble J.M., Devireddy R.V. Evaluation of methylcellulose and dimethyl sulfoxide as the cryoprotectants in a serum-free freezing media for cryopreservation of adipose-derived adult stem cells. Stem Cells Dev 2010, 19:513-522.
38. Wang B., Jenkins J.R., Trayhurn P. Expression and secretion of inflammation-related adipokines by human adipocytes differentiated in culture: integrated response to TNF-alpha. Am J Physiol Endocrinol Metab 2005, 288:E731-40.
39. Samad F., Uysal K.T., Wiesbrock S.M., Pandey M., Hotamisligil G.S., Loskutoff D.J. Tumor necrosis factor alpha is a key component in the obesity-linked elevation of plasminogen activator inhibitor 1. Proc Natl Acad Sci USA 1999, 96:6902-6907.
40. Sheu W.H.H., Lee W.J., Chang R.L., Chen Y.T. Plasma tumor necrosis factor alpha levels and insulin sensitivity in hypertensive subjects. Clin Exp Hypertens 2000, 22:595-606.
41. Keck C., Herchenbach D., Pfisterer J., Breckwoldt M. Effects of 17beta-estradiol and progesterone on interleukin-6 production and proliferation of human umbilical vein endothelial cells. Exp Clin Endocrinol Diabetes 1998, 106:334-339.
42. Ray P., Ghosh S.K., Zhang D.H., Ray A. Repression of interleukin-6 gene expression by 17 beta-estradiol: inhibition of the DNA-binding activity of the transcription factors NF-IL6 and NF-kappa B by the estrogen receptor. FEBS Lett 1997, 409:79-85.
43. Büyükafşar K., Yalçin I., Kurt A.H., Tiftik R.N., Sahan-Firat S., Aksu F. Rho-kinase inhibitor, Y-27632, has an antinociceptive effect in mice. Eur J Pharmacol 2006, 541:49-52.
44. Köksel O., Yildirim C., Tiftik R.N., Kubat H., Tamer L., Cinel L., et al. Rho-kinase (ROCK-1 and ROCK-2) upregulation in oleic acid-induced lung injury and its restoration by Y-27632. Eur J Pharmacol 2005, 510:135-142.
45. Yudkin J.S., Kumari M., Humphries S.E., Mohamed-Ali V. Inflammation, obesity, stress and coronary heart disease: is interleukin-6 the link?. Atherosclerosis 2000, 148:209-214.